CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on pharmacogenomics, linking genetic variations to drug responses. It aims to enhance clinical practice by training researchers to analyze genetic data and improve drug therapy outcomes through collaborative efforts across Europe and the US.
Pharmacogenomics is the scientific discipline that relates inter-individual variation in drug response to genetic variation.
While there have been major advances in basic genomic knowledge and genotyping technologies, translation into clinical practice has been slow.
It is essential we quicken the pace of translational research in pharmacogenomics - at present, we cannot define which patients are going to respond to drugs, and which patients are going to develop adverse drug reactions.
In this I…
ROBERT BOSCH GESELLSCHAFT FUR MEDIZINISCHE FORSCHUNG MBH
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, Tuebingen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, Liverpool
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Slovenia, Ljubljana
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Russia, St.-Petersburg
Type: Public body
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
